F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

The New York Times – Business:

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

Carl Zimmer
Author: Carl Zimmer

This post first appeared in The New York Times – Business. Read the original article.